Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-07-31
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim will be to determine whether the patients would prefer daily treatment or being allowed to skip one day per week.
Other aims will be to determine the effect of skipping a day on plasma levels of urea nitrogen and creatinine.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
STarting incrEmental Prescription of Peritoneal Dialysis
NCT06642597
Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
NCT02044614
Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients
NCT04603014
Intensive Versus Regular Dosage For PD In AKI.
NCT03438877
Biological Determinants of Peritoneal Dialysis
NCT02694068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The quality of life questionnaire to be used will be the Dialysis Symptom Index (DSI) which has a range of 0 to 150 with a high score reflecting worse quality of life.
The chemical to be measured will be the plasma urea nitrogen in mg/dl and the plasma creatinine in mg/dl as measured by the clinical laboratory.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peritoneal Dialysis Daily
Each patient will compare their regular daily treatment with the effect of skipping a single day of treatment. There will be no other intervention.
Skip one day of peritoneal dialysis treatment
Skip one day of peritoneal dialysis treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skip one day of peritoneal dialysis treatment
Skip one day of peritoneal dialysis treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent change in the dialysis prescriptoin
* recent peritonitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Timothy Meyer
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
75365
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.